Tonic-Clonic Seizure Treatment Market will grow at highest pace owing to increasing research and development in novel drug development

 


Tonic-clonic seizure, also known as grand mal seizure, is characterized by an abrupt loss of consciousness accompanied by body stiffening (tonic phase) followed by shaking or jerking of the limbs (clonic phase). Currently available treatment options such as Valproate, Levetiracetam and Phenytoin aim to control the spread of excessive or irregular neuronal activity in the brain which causes seizures. However, these drugs have side effects and may not be effective in all cases. This has propelled research into developing more efficacious and safe drugs for tonic-clonic seizure treatment.

The Global Tonic-clonic Seizure Market is estimated to be valued at US$ 3.1 billion in 2024 and is expected to exhibit a CAGR of 4.5% over the forecast period 2024-2029.

Key Takeaways
Key players operating in the tonic-clonic seizure treatment are UCB, Pfizer, Johnson and Johnson, Abbott, GlaxoSmithKline and Sunovion Pharmaceuticals.

Growing prevalence of epilepsy disorders globally is a major factor driving the demand for tonic-clonic seizure treatment drugs. According to the World Health Organization (WHO), around 50 million people worldwide have epilepsy with close to 80% of them living in developing nations.

Technological advancements in the field of neuroscience and central nervous system drugs have enabled researchers to gain better understanding of the disease pathology and design drugs that selectively target epileptic circuits and signalling pathways in the brain linked to seizure generation. This has opened up possibilities for developing next-generation anti-seizure medications.

Market Trends
Increasing focus on developing oral anti-seizure drugs: Currently most anti-seizure drugs available are generic first generation drugs. However, second generation anti-seizure drugs being developed have better tolerability and efficacy profiles.

Rise in novel drug delivery technologies: Newer technologies such as nanomedicine are enabling development of drugs with improved bioavailability, reduced side effects and targeted delivery to the brain. This is fast emerging as an attractive avenue for industry players.

Market Opportunities
High unmet needs in developing countries presents significant opportunity for low-cost generic anti-seizure drugs.

Focus on precision medicines and personalized treatment approaches tailored to individual patient profiles based on clinical as well as genetic/molecular factors offers a lucrative long-term opportunity.

Impact of COVID-19 on Tonic-clonic Seizure Market Growth
The COVID-19 pandemic has adversely impacted the growth of the tonic-clonic seizure market. During the peak of the pandemic in 2020, most countries went under lockdown which restricted the movement of people. This led to decrease in number of patient visits to neurologists for treatment and diagnosis of tonic-clonic seizures. As hospitals focused majorly on treatment of COVID-19 patients, resources were diverted from other therapies and surgeries. This resulted in postponement of non-urgent procedures and elective surgeries for patients suffering from tonic-clonic seizures.
However, with rapid vaccination drives in 2021, several economies were able to lift lockdown restrictions and normalcy was restored in healthcare services. This helped the tonic-clonic seizure market to bounce back. Additional funding by governments globally for research in seizure treatment aided market growth. Teleconsultations also helped patients to continue their treatment plan and follow-ups with neurologists remotely during lockdowns. In the coming years, growing awareness about epilepsy management and availability of innovative drugs are expected to drive further growth of this market.

Concentration of Tonic-clonic Seizure Market in terms of Value
The United States accounts for the largest share of the global tonic-clonic seizure market in terms of value. This is primarily due to high prevalence of epilepsy in the country and availability of advanced treatment options. According to CDC estimates, over 3 million people in the US suffer from epilepsy. Favorable reimbursement policies for anti-seizure medications also support high demand. Europe is the second largest regional market driven by rising geriatric population and increasing awareness. Countries like Germany, United Kingdom and France have emerged as major revenue generators. The market is also growing significantly in Asia Pacific region supported by improving healthcare infrastructure and economic growth in nations like China and India.

Fastest Growing Region in Tonic-clonic Seizure Market
Asia Pacific region is poised to witness the fastest growth in the tonic-clonic seizure market during the forecast period. This is attributed to growing patient pool, rising healthcare spending, lower treatment costs and increasing focus of international players on emerging Asian economies. Initiatives by governments to spread awareness about epilepsy management also supports market expansion. In addition, with improving standards of living, people are able to afford advanced anti-seizure drugs. Countries like China, India and South Korea are expected to drive the market growth in Asia Pacific region.

Get more insights on this topic : https://nouw.com/ajay100/tonic-clonic-seizure-market-is-estimated-to-witness-significant-growth-owing-to-increase-prevalence-38618762

What Are The Key Data Covered In This Tonic-clonic Seizure Market Report?

:- Market CAGR throughout the predicted period

:- Comprehensive information on the aspects that will drive the Tonic-clonic Seizure's growth between 2024 and 2031.

:- Accurate calculation of the size of the Tonic-clonic Seizure and its contribution to the market, with emphasis on the parent market

:- Realistic forecasts of future trends and changes in consumer behaviour

:- Tonic-clonic Seizure Industry Growth in North America, APAC, Europe, South America, the Middle East, and Africa

:- A complete examination of the market's competitive landscape, as well as extensive information on vendors

:- Detailed examination of the factors that will impede the expansion of Tonic-clonic Seizure vendors

About Author:

Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. (https://www.linkedin.com/in/ravina-pandya-1a3984191)

*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it

Comments

Post a Comment

Popular posts from this blog

Laser Projection Market is to Witness High Growth Owing to Advancements in RGB Laser Projection Technology

Image
  The laser projection market involves the usage of laser diodes and phosphor wheels to project images instead of traditional light bulbs and rotating color wheels. Laser projection technology offers a variety of benefits over conventional projection including high brightness levels, long lifespan, high resolutions, and high contrast ratios. Laser projectors are increasingly being used for entertainment and commercial applications such as cinemas, digital signage, and conferences & seminars. The demand for   Laser Projection Market is driven by the superior image quality, higher resolutions and brighter images they provide compared to conventional projectors. The laser projection market is estimated to be valued at   USD 17.52 Bn in 2024   and is expected to reach   USD 56.28 Bn by 2031,  growing at a compound annual growth rate  (CAGR) of 18.1% from 2024 to 2031.  Key Takeaways Key players: Key players operating in the laser projection...
Read more

AL Amyloidosis Diagnostics is to Witness High Growth due to Advancements in Molecular Diagnostics and Flow Cytometry

Image
AL amyloidosis, also called primary (AL) amyloidosis, is a plasma cell disorder characterized by the buildup of abnormal protein deposits known as amyloid in tissues and organs. AL amyloidosis can affect the heart, kidneys, liver, nervous system, and digestive system. Early and precise diagnosis of AL Amyloidosis Diagnostics Market is very important for effective treatment and management of the disease. The AL amyloidosis diagnostic market is estimated to be valued at  USD 1.068 billion in 2024   and is expected to reach   USD 1.693 billion by 2031 , growing at a compound annual growth rate   (CAGR) of 6.8% from 2024 to 2031. Key Takeaways Key players operating in the AL amyloidosis diagnostics are Siemens Healthineers, Abbott Laboratories, IMMUNOConcepts, PrognostiX, Ark Diagnostics. The key opportunities in the AL amyloidosis diagnostics market include development of minimally invasive diagnostic techniques, adoption of PET imaging for diagnosis, advanceme...
Read more

Navigating the Stuttering Treatment Market: Top Solutions for Effective Speech Therapy

Image
The stuttering treatment market involves speech therapy techniques that help reduce or eliminate stuttering or stammering symptoms. Stuttering or stammering occurs when the flow of speech is disrupted by involuntary blocking, repetition, or prolongation of certain sounds. Such involuntary disruptions create difficulties in expressing thoughts fluently which can negatively impact an individual's self-confidence and social interactions. The need for effective Stuttering Market treatment solutions is rising due to the availability of advanced methods such as modified fluency shaping techniques, delayed auditory feedback devices, and self-therapy programs. The Global Stuttering Market is estimated to be valued at   USD 51.5 million in 2024   and is expected to reach   USD 150.1 million by 2031 , growing at a compound annual growth rate   (CAGR) of 11.3% from 2024 to 2031. Key Takeaways Key players operating in the stuttering treatment market are Johnson & Johns...
Read more